Wegovy vs Zepbound: which one should I ask for and where do I get either online?

Short answer

• Both are once‑weekly prescription injectables for chronic weight management. Zepbound (tirzepatide, by Eli Lilly) tends to produce larger average weight loss in clinical trials than Wegovy (semaglutide, by Novo Nordisk).
• Ask your clinician about tirzepatide (Zepbound) if your goal is maximal weight loss and you have no contraindications. Ask about semaglutide (Wegovy) if you (or your clinician) prefer a drug with a longer real‑world track record or if tirzepatide causes intolerable GI side effects. Final choice depends on medical history, tolerability and insurance/cost.

Key differences (brief)

• Mechanism: Wegovy = semaglutide (GLP‑1 receptor agonist). Zepbound = tirzepatide (dual GIP + GLP‑1 agonist).
• Efficacy: In trials, tirzepatide generally produced greater average percent weight loss than semaglutide. Individual response varies.
• Side effects: Both cause GI effects (nausea, vomiting, diarrhea, constipation); tirzepatide can be a bit more likely to cause GI symptoms for some people. Both carry rare risks (pancreatitis, gallbladder problems) and boxed warnings/contraindications related to thyroid C‑cell tumors / MEN2 — discuss family history. Not for use in pregnancy.
• Dosing/administration: Both are subcutaneous injections given weekly at home.

Where to get them online (legitimate options)

1. Get a prescription first — via:
   • Your primary care doctor or an endocrinologist (best if you have other medical problems like diabetes).
   • A telehealth weight‑management service that evaluates you and prescribes if appropriate. Legitimate services that commonly offer GLP‑1/tirzepatide evaluations include: PlushCare, Ro (Roman), Hims & Hers, Calibrate, HeyDoctor, and Onduo. (Availability, formularies and exact medications offered vary by service and state.)
2. Fill the prescription at a reputable pharmacy / specialty pharmacy: CVS Specialty, Accredo, OptumRx Specialty, or your local retail pharmacy if they carry it. Many insurers route Wegovy and Zepbound through specialty pharmacies.
3. Manufacturer resources and savings programs:
   • Novo Nordisk (Wegovy) and Eli Lilly (Zepbound) have patient portals, savings cards or support programs for commercially insured or cash‑paying patients — check the manufacturers’ official websites for up‑to‑date programs and eligibility.
4. Price help: Use GoodRx/SingleCare for cash prices and coupons, but only fill with a prescription at a licensed pharmacy. Avoid overseas or “no-prescription” online sellers — they may be unsafe or illegal.

Practical points before you ask your clinician

• Check for contraindications: personal or family history of medullary thyroid carcinoma (MTC) or MEN2, pregnancy, current/previous pancreatitis, and interactions with insulin or sulfonylureas (doses may need adjustment).
• Expect baseline labs (A1c if diabetic, kidney/liver tests) and follow‑up monitoring.
• Cost/coverage: Both can be expensive out of pocket; coverage is highly variable. Ask your insurer and the prescribing service which drug is covered and what prior‑authorization steps are needed.
• Trial and tolerance: If you try one and don’t tolerate it, switching to the other is a common strategy.

If you want, tell me:

• Your major goals (how much weight you hope to lose), any major medical conditions (diabetes, pancreatitis, pregnancy plans, thyroid cancer family history), and whether you have insurance — I can give a more tailored suggestion and point to specific telehealth services and specialty pharmacies available for your situation.